India could get 4th Covid vaccine as Zydus Cadila set to seek nod for ZyCoV-D

This could also be India's first vaccine for children aged 12 years and above as the company has conducted trials on the age group. The decision, however, lies with the regulator, reports Sohini......

Cadila launches Remdesivir in India at Rs 2,800 per vial

Drug firm Zydus Cadila on Thursday said it has launched Remdesivir under the brand name Remdac, used to treat patients suffering from severe symptoms of COVID-19, in the Indian market.  ......

India's children may get 2 Covid vaccines by December

While Bharat Biotech’s Covaxin is in trials among children already, Serum Institute of India will begin Novavax vaccine trials on children from July, whereas the Pfizer vaccine has been......

Only Covaxin available for 15-18-yr-olds, for now

Bharat Biotech's Covaxin is likely to be the only COVID-19 vaccine available, for now, for children in the age group of 15-18 years, who will be inoculated from January 3, official sources said.......

Another Indian COVID-19 vaccine candidate gets nod for human trial

Zydus plans to initiate the clinical trials of ZyCoV-D in July 2020 across multiple sites in India. In animal studies the vaccine was found to elicit a strong immune response in multiple animal......

Zydus Cadila to sell Sertraline in France

Zydus Cadila Healthcare Ltd on Tuesday said it has received approval from the French regulatory agency, AFSSAPS, to market Sertraline capsules 25 mg and 50 mg, in the French market.Sertraline is an......

Downturn is the time to attract young talent: D&B

The country's leading companies came together recently to discuss the HR challenges thrown at them in the backdrop of the global meltdown at a seminar 'HR challenges -- coping with the economic......

Cadila believes it has silver bullet to fight COVID-19

Can Interferon alfa-2b treat COVID-19 effectively?Sohini Dutt reports. Kindly note the image has been posted only for representational purposes. Photograph: PTI Photo Ahmedabad-based......